Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Diabetes Mellitus and CCR5[original query] |
---|
Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 2004 May 26 (3): 114-21. Yang B, Houlberg K, Millward A, Demaine |
Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2010 Dec . Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ |
Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways. BMC medical genetics 2014 15 103. Nazir Nyla, Siddiqui Khalid, Al-Qasim Sara, Al-Naqeb Dhek |
Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis. International urology and nephrology 2016 Apr . Bagci Binnur, Bagci Gokhan, Huzmeli Can, Sezgin Ilhan, Ozdemir Oztu |
Common and Rare Genetic Variation in CCR2, CCR5, or CX3CR1 and Risk of Atherosclerotic Coronary Heart Disease and Glucometabolic Traits. Circulation. Cardiovascular genetics 2016 Mar . Golbus Jessica R, Stitziel Nathan O, Zhao Wei, Xue Chenyi, Farrall Martin, McPherson Ruth, Erdmann Jeanette, Deloukas Panos, Watkins Hugh, Schunkert Heribert, Samani Nilesh J, Saleheen Danish, Kathiresan Sekar, Reilly Muredach |
CCR5-?32 gene polymorphism is related to celiac disease and autoimmune thyroiditis coincidence in patients with type 1 diabetes. Journal of diabetes and its complications 2016 Nov . S?omi?ski Bartosz, ?awrynowicz Urszula, My?liwska Jolanta, Ryba-Stanis?awowska Monika, Skrzypkowska Maria, My?liwiec Ma?gorzata, Brandt Agniesz |
CCR5-?32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes. Cytokine 2019 Feb 114 81-85. S?omi?ski Bartosz, ?awrynowicz Urszula, Ryba-Stanis?awowska Monika, Skrzypkowska Maria, My?liwska Jolanta, My?liwiec Ma?gorza |
Effects of CCR5 59029G/A polymorphism on the risk to diabetic nephropathy. Oncotarget 2018 1 8 (63): 106926-106934. Cao Mingfeng, Tian Zhenhua, Zhang Lin, Liu Ruiting, Guan Qingbo, Jiang Jinji |
Genetic variants linked to T2DM risk in Kurdish populations. Diabetes, metabolic syndrome and obesity : targets and therapy 2019 5 12 431-437. Golsheh Shadi, Keshavarzi Fatem |
Association of CCL2, CCR5, ELMO1, and IL8 Polymorphism with Diabetic Nephropathy in Malaysian Type 2 Diabetic Patients. International journal of chronic diseases 2019 2019 2053015. Yahya Mohd Jokha, Ismail Patimah Binti, Nordin Norshariza Binti, Akim Abdah Binti Md, Yusuf Wan Shaariah Binti Md, Adam Noor Lita Binti, Yusoff Maryam Jamiel |
Association of chemotactic cytokine receptor 5 (CCR5) gene polymorphism (59029 A/G, rs1799987) with diabetic kidney disease in patients with type 2 diabetes from Poland. Endokrynologia Polska 2022 Feb . Pokrzywnicka Patrycja, Kwiendacz Hanna, Nabrdalik Katarzyna, Hajzler Weronika, Adamczyk Piotr, Moczulski Dariusz, Trautsolt Wanda, Grzeszczak W?adys?aw, Gumprecht Janu |
Potential Genes Associated with COVID-19 and Comorbidity. International journal of medical sciences 2022 2 19 (2): 402-415. Feng Shanshan, Song Fuqiang, Guo Wenqiong, Tan Jishan, Zhang Xianqin, Qiao Fengling, Guo Jinlin, Zhang Lin, Jia |
Investigation of the Correlation Between the Polymorphism/Expression Level of RANTES and Its Receptor CCR5 Gene Promoter and Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy 2023 2 16 213-223. Chen Jie, Guo Weichang, Yin Hejia, Ma Liju, Li Shaoyou, Li Huifa |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: